Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress
- PMID: 28822080
- DOI: 10.1007/s12035-017-0726-9
Soluble Epoxide Hydrolase Inhibition Attenuates MPTP-Induced Neurotoxicity in the Nigrostriatal Dopaminergic System: Involvement of α-Synuclein Aggregation and ER Stress
Abstract
Soluble epoxide hydrolase (sEH) is widely expressed in the mammalian brain and possesses dual enzymatic activities, including C-terminal epoxide hydrolase (C-EH) which degrades epoxyeicosatrienoic acid (EET), a beneficial arachidonic acid metabolite. In the present study, the neuroprotective effect of sEH inhibition on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neurodegeneration of nigrostriatal dopaminergic system was investigated using genetic and pharmacological approaches. MPTP (15 mg/kg) was intraperitoneally injected in sEH knockout (KO) mice and C57BL/6J mice as wild-type (WT) mice. Compared with the MPTP-treated WT mice, MPTP-induced reductions in striatal dopamine content and nigral tyrosine hydroxylase level (TH, a biomarker of dopaminergic neurons) were less significant in the treated sEH mice. Furthermore, MPTP-induced HO-1 elevation (a redox-regulated protein), α-synuclein aggregation, and caspase 12 activation (a hallmark of ER stress) were less prominent in sEH KO mice than in WT mice. These data indicate that sEH KO mice are more resistant to MPTP-induced neurotoxicity. The pharmacological effect of N-[1-(1-oxopropyl)-4-piperidinyl]-N0-[4-(trifluoromethoxy)phenyl)-urea (TPPU, an sEH inhibitor) on MPTP-induced neurotoxicity was investigated in WT mice. TPPU (1 mg/kg, i.p.) attenuated MPTP-induced reduction in striatal dopamine content, TH-positive cell numbers, TH, and pro-caspase 9 protein levels (an initiator caspase of apoptosis) in mouse SN. Moreover, TPPU reduced MPTP-induced HO-1 elevation, α-synuclein aggregation and caspase 12 activation, indicating that TPPU is effective in attenuating MPTP-induced oxidative stress, apoptosis, protein aggregation, and ER stress. In conclusion, our study suggests that sEH is a potential target for developing therapies for parkinsonism. Furthermore, sEH inhibitors may be of clinical significance for treating CNS neurodegenerative diseases.
Keywords: ER stress; Oxidative stress; Parkinsonism; Soluble epoxide hydroxylase; TPPU; sEH KO mice; α-Synuclein aggregation.
Similar articles
-
Soluble epoxide hydrolase plays a key role in the pathogenesis of Parkinson's disease.Proc Natl Acad Sci U S A. 2018 Jun 19;115(25):E5815-E5823. doi: 10.1073/pnas.1802179115. Epub 2018 May 7. Proc Natl Acad Sci U S A. 2018. PMID: 29735655 Free PMC article.
-
Soluble Epoxide Hydrolase Deficiency or Inhibition Attenuates MPTP-Induced Parkinsonism.Mol Neurobiol. 2015 Aug;52(1):187-95. doi: 10.1007/s12035-014-8833-3. Epub 2014 Aug 17. Mol Neurobiol. 2015. PMID: 25128026
-
EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.Eur J Neurosci. 2008 Jul;28(1):41-50. doi: 10.1111/j.1460-9568.2008.06314.x. Eur J Neurosci. 2008. PMID: 18662333
-
Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.Free Radic Biol Med. 2013 Sep;62:186-201. doi: 10.1016/j.freeradbiomed.2013.05.042. Epub 2013 Jun 3. Free Radic Biol Med. 2013. PMID: 23743292 Review.
-
Soluble Epoxide Hydrolase Inhibition to Face Neuroinflammation in Parkinson's Disease: A New Therapeutic Strategy.Biomolecules. 2020 May 1;10(5):703. doi: 10.3390/biom10050703. Biomolecules. 2020. PMID: 32369955 Free PMC article. Review.
Cited by
-
Inhibition of soluble epoxide hydrolase ameliorates cerebral blood flow autoregulation and cognition in alzheimer's disease and diabetes-related dementia rat models.Geroscience. 2025 Jun;47(3):4429-4449. doi: 10.1007/s11357-025-01550-8. Epub 2025 Feb 4. Geroscience. 2025. PMID: 39903369 Free PMC article.
-
Cytochrome P450-derived eicosanoids in brain: From basic discovery to clinical translation.Adv Pharmacol. 2023;97:283-326. doi: 10.1016/bs.apha.2022.11.002. Epub 2023 Jan 11. Adv Pharmacol. 2023. PMID: 37236762 Free PMC article.
-
Soluble Epoxide Hydrolase and Brain Cholesterol Metabolism.Front Mol Neurosci. 2020 Jan 29;12:325. doi: 10.3389/fnmol.2019.00325. eCollection 2019. Front Mol Neurosci. 2020. PMID: 32063836 Free PMC article. Review.
-
Cytochrome P450 Metabolism of Polyunsaturated Fatty Acids and Neurodegeneration.Nutrients. 2020 Nov 16;12(11):3523. doi: 10.3390/nu12113523. Nutrients. 2020. PMID: 33207662 Free PMC article. Review.
-
Role of Soluble Epoxide Hydrolase in Metabolism of PUFAs in Psychiatric and Neurological Disorders.Front Pharmacol. 2019 Jan 30;10:36. doi: 10.3389/fphar.2019.00036. eCollection 2019. Front Pharmacol. 2019. PMID: 30761004 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials